Brind.
  1. Trump pressured the FDA regarding product authorization, leading to the resignation of Marty Makary.
  2. The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA.

Donald Trump instructed the FDA to accelerate the drug review process.

27 reports, 6 independent Updated Oct 9
Gone quiet
Reports
27
Developments
2
Repetition
96%

New informationRepeats or wire copies

AI-generated analysis. Brind wrote this summary from the reports listed below. It can be wrong. Each section says how much you can rely on it, and the sources are linked so you can check.

What happened

Well supportedReported by 6 independent outlets

Donald Trump instructed the FDA to accelerate the drug review process.

Who's involved

What this event is mainly about
FDADonald Trump

How it developed

Newest first. Tap a step to see who reported it.
  1. Steven Abrams commented on the FDA's nutrition update review, which is part of a Trump administration initiative.Sub-event
  2. Trump directed the FDA to speed up drug approval reviews.1 source

Keep exploring

Part of

The administration has signed an executive order and issued priority vouchers to accelerate the drug approval process through the FDA. All 1 developments

Within Trump pressured the FDA regarding product authorization, leading to the resignation of Marty Makary.

The entities involved

Coverage

Newest first; wire copies grouped
20 more outlets ran the same wire story